AMDL, Inc. reported that its China subsidiary, Jade Pharmaceutical, signed on Heze Mudan Medicals Co. Ltd. to distribute Jade’s Domperidone tablets, a drug used to treat nausea and vomiting. Jade expects the arrangement to add at least $2.3 million annually to sales, which is not insignificant for a company that booked revenues of just $2.4 million in the second quarter of 2007.  More details...

Stock Symbol: (AMEX: ADL)